How Stem Cell Therapy Can Keep the Immune System Under Control
26 Apr 12
A new study, appearing in Cell Stem Cell and led by researchers at the University of Southern California, outlines the specifics of how autoimmune disorders can be controlled by infusions of mesenchymal stem cells.
Mesenchymal stem cells (MSC) are highly versatile stem cells that originate from the mesoderm, or middle layer of tissue, in a developing embryo. MSC can be isolated from many different kinds of human tissue, including bone marrow and the umbilical cord.
Principal investigator Songtao Shi, professor at the Herman Ostrow School of Dentistry of USC Center for Craniofacial Molecular Biology, said that recent studies have shown the benefits of administering MSC to patients with immune-related disorders such as graft versus host disease, systemic lupus erythematosus, rheumatoid arthritis, and more.
These studies showed that infusions of MSC appeared to quell the production and function of overactive immune cells, including T- and B-lymphocytes. However, the specific mechanism behind how MSC get the immune cells under control hasn’t been fully understood.
“Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis” shines light on how infused MSCs target and defeat overactive immune cells. Examining the effects of MSC infusion in mice with systemic sclerosis (SS)-like immune disorders, Shi and his colleagues discovered that a specific cellular mechanism known as the FAS/FAS-ligand pathway was the key to the remarkable immune system benefits.
Specifically, in mice with SS-like disorders, infusions of MSC caused T-lymphocyte death with FASL/FAS signaling and lessened symptoms of the immune disorder. However, MSC deficient in FAS-ligand failed to treat immune disorders in SS-afflicted mice.
With the hopeful results of the animal model study in mind, Shi’s colleagues in China performed a pilot study with patients suffering from systemic sclerosis. Infusions of MSCs provided similar clinical benefits to patients, and experimental analysis revealed that the FASL/FAS pathway was also at work in humans with SS.
The identification of the cellular workings responsible for the stem cell treatments’ success may eventually help doctors find optimal cell-based treatment for some immune diseases, Shi said.
Basic research portions of this study were supported by the National Institute of Dental and Craniofacial Research and the California Institute for Regenerative Medicine. Clinical studies were supported by a grant from the China Major International (Regional) Joint Research Project.
Asha Green, Daniel Ip and Somkene Okwuego have their dental educations paid for, thanks to a National Health Service Corps scholarship that requires them to spend two years practicing in a health professional shortage area. IT’S A STATISTIC THAT’S NEVER FAR from the mind of Asha Green DDS ’26: just 3.7 percent of dentists in […]
Zhaoyang Liu Assistant Professor LAST YEAR, Ostrow welcomed researcher Zhaoyang Liu to the Trojan Dental Family. The tenure-track assistant professor earned her bachelor’s degree in biological sciences in China before pursuing a master’s degree in cellular, molecular and structural biology from Miami University-Ohio and a doctorate in biology from the University of Rochester-New York. […]
Alon Frydman PERIO ’06 Director, Continuing Education LAST YEAR, Ostrow’s CE department launched its official podcast, Louped In, which looks at various topics in dentistry from the foremost experts in the field. We caught up with its host, Associate Professor of Clinical Dentistry Alon Frydman. WHAT GOES INTO PREPARING FOR RECORDING AN EPISODE […]
The new tech allows endodontists to see in three dimensions, allowing more accurate diagnoses, treatment and evaluation. ENDODONTISTS SPECIALIZE IN SAVING NATURAL DENTITION, mostly focusing on the tooth’s interior. They live and die by imaging, both to diagnose what’s going on inside a tooth as well as to see how a treatment is working. Historically, […]
USC researcher Dechen Lin has created miniature organs — with the hope of fighting a rare type of cancer. CANCERS THAT IMPACT THE JUNCTION of the esophagus and the stomach are rare — but debilitating. They get less attention than breast, prostate or lung cancers — and 85 percent of patients diagnosed with gastroesophageal junction […]